Showing results (71-80 of 176) with videos related to
Sort By:
Pageof 18
Neuroscience|May 1, 1996
A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesiaK Eberle-Wang, I Lucki, M F ChesseletPsychopharmacology|January 1, 1987
The role of the aural head shake reflex in serotonin-mediated head shaking behaviorI Lucki, K M Eberle, N Minugh-PurvisThe Journal of Pharmacology and Experimental Therapeutics|February 25, 2000
Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptorsD A Knobelman, H F Kung, I LuckiBiochemical Society Transactions|March 21, 2007
Emerging use of non-viral RNA interference in the brainJ F Cryan, D R Thakker, D HoyerBrain Research|June 18, 1990
Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridineS Wieland, M S Kreider, P McGonigle, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Serotonergic involvement in haloperidol-induced catalepsyB S Neal-Beliveau, J N Joyce, I LuckiActa Psychiatrica Scandinavica|January 1, 1983
Neuroendocrine regulation in depressed postmenopausal women and healthy subjectsJ D Amsterdam, A Winokur, I Lucki, et al.British Journal of Clinical Pharmacology|February 1, 1987
Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory functionI Lucki, K Rickels, M A Giesecke, et al.Genes, Brain, and Behavior|November 30, 2013
Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axisR M Stilling, T G Dinan, J F CryanMolecular Psychiatry|December 21, 2011
Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depressionR M O'Connor, T G Dinan, J F CryanPageof 18